Institut De Recherches Internationales Servier (i.r.i.s.)

This early-stage study looks at how a single dose of the drug vorasidenib is handled by the body in people with severe liver impairment versus those with normal liver function. Researchers will measure drug levels in the blood and monitor for side effects. The study involves 20 p…